Düsseldorf/Germany: After three fascinating and very interesting days, MEDICA 2019 ended on 21 November. Once again, the world’s leading medical trade fair was a huge success. At STORZ MEDICAL’s exhibition stand in hall 10, the full range of the company’s therapy options was on display – including several innovations. Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system, a unique procedure for patients with Alzheimer's disease, was explained in detail by Dr Rafael Storz, who also answered the visitors’ questions. In addition, the new MAGNETOLITH® for Extracorporeal Magnetotransduction Therapy (EMTT®) and the redesigned MODULITH® SLC were also at the centre of attention. Both devices were unveiled and presented during the trade fair.

STORZ MEDICAL has received the CE approval for the MODULITH^® SLC. The areas of application of this innovative shock wave system are ischaemic heart failure, coronary heart disease, and angina pectoris.

Being designed for penetration depths of between 0 and 150 mm, the MODULITH^® SLC is well prepared to master any challenge in daily clinical practice, reaching target areas from the apex to the posterior wall of the myocardium. The proven shock wave technology developed by STORZ MEDICAL makes use of a cylindrical coil in combination with a parabolic reflector for focusing. The coil and reflector are perfectly adapted to the specific medical requirements. The long-life cylindrical coil lasts for several hundred treatments.